1-4 of 4
Manel Esteller
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

ERBB4-Mediated Signaling Is a Mediator of Resistance to PI3K and BTK Inhibitors in B-cell Lymphoid Neoplasms

Alberto J. Arribas, Sara Napoli, Luciano Cascione, Laura Barnabei, Giulio Sartori, Eleonora Cannas, Eugenio Gaudio, Chiara Tarantelli, Afua A. Mensah, Filippo Spriano, Antonella Zucchetto, Francesca M. Rossi, Andrea Rinaldi, Manuel Castro de Moura, Sandra Jovic, Roberta Bordone Pittau, Anastasios Stathis, Georg Stussi, Valter Gattei, Jennifer R. Brown, Manel Esteller, Emanuele Zucca, Davide Rossi, Francesco Bertoni
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2024) 23 (3): 368–380.
https://doi.org/10.1158/1535-7163.MCT-23-0068
Published: 04 March 2024
View articletitled, ERBB4-Mediated Signaling Is a Mediator of Resistance to PI3K and BTK Inhibitors in B-cell Lymphoid Neoplasms
Open the PDF for ERBB4-Mediated Signaling Is a Mediator of Resistance to PI3K and BTK Inhibitors in B-cell Lymphoid Neoplasms in another window
Includes: Supplementary data
Journal Articles

Genomic and Molecular Screenings Identify Different Mechanisms for Acquired Resistance to MET Inhibitors in Lung Cancer Cells

Pol Gimenez-Xavier, Eva Pros, Ester Bonastre, Sebastian Moran, Ana Aza, Osvaldo Graña, Gonzalo Gomez-Lopez, Sophia Derdak, Marc Dabad, Anna Esteve-Codina, Jose R. Hernandez Mora, Diana Salinas-Chaparro, Manel Esteller, David Pisano, Montse Sanchez-Cespedes
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2017) 16 (7): 1366–1376.
https://doi.org/10.1158/1535-7163.MCT-17-0104
Published: 04 July 2017
View articletitled, Genomic and Molecular Screenings Identify Different Mechanisms for Acquired Resistance to MET Inhibitors in Lung Cancer Cells
Open the PDF for Genomic and Molecular Screenings Identify Different Mechanisms for Acquired Resistance to MET Inhibitors in Lung Cancer Cells in another window
Includes: Supplementary data
Journal Articles

Tumor-Related Molecular Mechanisms of Oxaliplatin Resistance

Eva Martinez-Balibrea, Anna Martínez-Cardús, Alba Ginés, Vicenç Ruiz de Porras, Catia Moutinho, Laura Layos, José Luis Manzano, Cristina Bugés, Sara Bystrup, Manel Esteller, Albert Abad
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2015) 14 (8): 1767–1776.
https://doi.org/10.1158/1535-7163.MCT-14-0636
Published: 05 August 2015
View articletitled, Tumor-Related Molecular Mechanisms of Oxaliplatin Resistance
Open the PDF for Tumor-Related Molecular Mechanisms of Oxaliplatin Resistance in another window
Journal Articles

Angiostatic activity of DNA methyltransferase inhibitors

Debby M.E.I. Hellebrekers, Kam-Wing Jair, Emmanuelle Viré, Sayaka Eguchi, Nicole T.H. Hoebers, Mario F. Fraga, Manel Esteller, François Fuks, Stephen B. Baylin, Manon van Engeland, Arjan W. Griffioen
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2006) 5 (2): 467–475.
https://doi.org/10.1158/1535-7163.MCT-05-0417
Published: 27 February 2006
View articletitled, Angiostatic activity of DNA methyltransferase inhibitors
Open the PDF for Angiostatic activity of DNA methyltransferase inhibitors in another window